martes, 4 de noviembre de 2025

Neoadjuvant Therapy in NSCLC: 5-Year Study Unveils Nivolumab’s Curative Potential Mark G. Kris, MD November 03, 2025

https://www.medscape.com/viewarticle/neoadjuvant-therapy-nsclc-5-year-study-unveils-nivolumabs-2025a1000sfi

No hay comentarios:

Publicar un comentario